Global Tech Summit 2023 to address digital transformation of pharma & drug discovery
23 January 2023 | News
Regulators must find a balance between encouraging innovation and protecting public health: Say Experts
The pharmaceutical industry is buzzing with anticipation for the Global Tech Summit 2023, set to take place in Visakhapatnam from February 16–17. Recently, the Global Tech Summit team, led by Dr Srinubabu Gedela, CEO of Pulsus Group, held a roadshow and business-to-biopharma digital transformation policy design meeting in Nagpur as a part of the 72nd Indian Pharmaceutical Congress, held between 20th and 22nd January 2023.
The event brought together 50 influential policymakers, global pharma experts, and other decision-makers to discuss how the Global Tech Summit is becoming a revolutionary platform for the application of cutting-edge technology in drug discovery, regulatory affairs, and making medicine more affordable for all.
During the Round Table Series of Biopharma Digital Transformation Policy Deliberations, participants heard from key figures in the industry about the challenges facing regulators in digital healthcare.
Dr Dominique Jordan, President of the International Pharmaceutical Federation, highlighted the potential impact of technology in revolutionising drug discovery. "Digital transformation can benefit the pharmaceutical industry in a variety of ways, including improved drug development, patient care, and interaction; technology helps to make medicine more affordable and accessible; it reduces carbon footprint; and it improves supply chain transparency." Dr Jordan said.
The Global Tech Summit team and experts in attendance also discussed the importance of using digital technologies in drug discovery, such as artificial intelligence and machine learning.
"Regulators must find a balance between encouraging innovation and protecting public health," said Dr H.G. Koshia, Commissioner of Food and Drug Control Administration, Government of Gujarat.
Abhijit Ghoshi, Assistant Drug Controller at the Medical Device Standards Control Organisation said, "Digital transformation in the pharmaceutical industry is inevitable, and India should take the lead in developing policies that encourage innovation while protecting public health".
